70 related articles for article (PubMed ID: 3031627)
1. Studies on griseolic acid derivatives. III. Synthesis and biological activities of the adducts of griseolic acid and their base exchanged derivatives.
Murofushi Y; Kimura M; Kuwano H; Iijima Y; Yamazaki M; Kaneko M
Nucleic Acids Symp Ser; 1986; (17):45-8. PubMed ID: 3031627
[TBL] [Abstract][Full Text] [Related]
2. Studies on griseolic acid derivatives. I. Synthesis of substituted derivatives of griseolic acid at the N1, C6, C2' or C7' position and their biological activities.
Kaneko M; Murofushi Y; Kimura M; Yamazaki M; Iijima Y
Nucleic Acids Symp Ser; 1985; (16):89-92. PubMed ID: 3003711
[TBL] [Abstract][Full Text] [Related]
3. Studies on griseolic acid derivatives. VII. Synthesis and phosphodiesterase inhibitory activity of the C4'-C5' hydrogenated products of griseolic acid and their base-exchanged derivatives.
Murofushi Y; Kimura M; Kuwano H; Iijima Y; Yamazaki M; Kaneko M
Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):3760-9. PubMed ID: 2854497
[No Abstract] [Full Text] [Related]
4. Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Taxonomy, isolation and characterization.
Nakagawa F; Okazaki T; Naito A; Iijima Y; Yamazaki M
J Antibiot (Tokyo); 1985 Jul; 38(7):824-9. PubMed ID: 2993218
[TBL] [Abstract][Full Text] [Related]
5. Studies on griseolic acid derivatives. IV. Synthesis and phosphodiesterase inhibitory activity of acylated derivatives of griseolic acid.
Murofushi Y; Kimura M; Iijima Y; Yamazaki M; Kaneko M
Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1036-43. PubMed ID: 3038344
[No Abstract] [Full Text] [Related]
6. Synthesis and phosphodiesterase activity of carboxylic acid mimetics of cyclic guanosine 3',5'-monophosphate.
Tulshian D; Czarniecki M; Doll RJ; Ahn HS
J Med Chem; 1993 Apr; 36(9):1210-20. PubMed ID: 8387599
[TBL] [Abstract][Full Text] [Related]
7. Studies on griseolic acid derivatives. VI. Synthesis and phosphodiesterase-inhibitory activity of 6- and N1-substituted derivatives of griseolic acid.
Murofushi Y; Kimura M; Iijima Y; Yamazaki M; Kaneko M
Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1309-20. PubMed ID: 2843300
[No Abstract] [Full Text] [Related]
8. Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. II. The structure of griseolic acid.
Takahashi S; Nakagawa F; Kawazoe K; Furukawa Y; Sato S; Tamura C; Naito A
J Antibiot (Tokyo); 1985 Jul; 38(7):830-4. PubMed ID: 2993219
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors.
Xia Y; Chackalamannil S; Czarniecki M; Tsai H; Vaccaro H; Cleven R; Cook J; Fawzi A; Watkins R; Zhang H
J Med Chem; 1997 Dec; 40(26):4372-7. PubMed ID: 9435906
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
11. Griseolic acid, a cAMP phosphodiesterase inhibitor, and its ester: increase in cellular cAMP levels and reduction of intraocular pressure.
Yamazaki M; Yasumoto T; Iijima Y; Yokoyama T; Fukami S; Kaneko M; Kiuchi Y; Mishima H
Adv Second Messenger Phosphoprotein Res; 1990; 24():502-6. PubMed ID: 1698412
[No Abstract] [Full Text] [Related]
12. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of griseolic acid B by pi-face-dependent radical cyclization.
Knapp S; Madduru MR; Lu Z; Morriello GJ; Emge TJ; Doss GA
Org Lett; 2001 Nov; 3(22):3583-5. PubMed ID: 11678714
[TBL] [Abstract][Full Text] [Related]
14. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of griseolic acids: incorporation of 13C-labeled compounds into griseolic acid A.
Miyakoshi S; Haruyama H; Shioiri T; Takahashi S; Torikata A; Yamazaki M
J Antibiot (Tokyo); 1992 Mar; 45(3):394-9. PubMed ID: 1315729
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
17. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of griseolic acid, a cyclic AMP phosphodiesterase inhibitor with an adenine group.
Iijima Y; Nakagawa F; Handa S; Oda T; Naito A; Yamazaki M
FEBS Lett; 1985 Nov; 192(2):179-83. PubMed ID: 2998865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
